ABBV Jan 2025 210.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:45AM EDT. Market open.
| Previous close | 1.2400 |
| Open | 1.3300 |
| Bid | 0.9700 |
| Ask | 1.2400 |
| Strike | 210.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.2400 - 1.3300 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.61k |
ZacksPharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
FDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
PR NewswireAbbVie Declares Quarterly Dividend
The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share.
- PR Newswire
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
AbbVie (NYSE: ABBV) today announced that the independent directors of the board have selected Roxanne S. Austin as lead independent director, effective July 1, 2024. Ms. Austin succeeds Glenn F. Tilton, who has served as lead independent director since 2013. Mr. Tilton will continue to serve on the AbbVie Board as an independent director.
© 2024 Yahoo. All rights reserved.